Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Intra-Articular Vitamin D3 Injection for Treatment of Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial

NCT07929103 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07929103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Intra-Articular Vitamin D3 Injection for Treatment of Temporomandibular Joint Osteoarthritis: A Randomized Clinical Trial
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 1, 2026
Completion date
June 30, 2027
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

temporomandibular joint osteoarthritis

Arms

As registered; 2 arms.

  • Group will be injected with Vitamin D3 Active comparatorVitamin D3 (Cholecalciferol)

    Joint will be injected with 1ml of vitamin D3 ( Cholecalciferol 200.000 IU )

  • Group will be injected with Normal Saline Placebo comparatorNormal Saline

    Joint will be injected with 1ml of normal saline

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Change from Baseline in Pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity (worse outcome) 6 Months following end of treatment

Lead sponsor's other trials

Cairo University, most recent start first.